AliTabarrokiMD

PubMed

• 13 citations
  Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
  Betty K. Hamilton, Valeria Visconte, Xuefei Jia, Ali Tabarroki, Hideki Makishima, Donna Abounader, Matt Kalaycio, Mikkael A. Sekeres, Ronald Sobecks, Hien D. Liu, Bria...> ;American Journal of Hematology. 2016 Jun 1
• 4 citations
  Molecular and phenotypic heterogeneity of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
  Valeria Visconte, Ali Tabarroki, Edy Hasrouni, Jaroslaw P. Maciejewski, Eric D. Hsi, Ramon V. Tiu, Heesun J. Rogers> ;Leukemia & Lymphoma. 2016 Jan 2
• 2 citations
  Safe and effective use of ponatinib in a patient with chronic myeloid leukemia and acute venous thromboembolism on therapeutic anti-coagulation
  William Shomali, Cheryl Redmond, Samjhana Bogati, Cassandra Zimmerman, Valeria Visconte, Ali Tabarroki, Matt Kalaycio, Ramon V. Tiu> ;Leukemia & Lymphoma. 2016 Jan 2
• 4 citations
  Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes
  Jing Ai, Valeria Visconte, Ali Tabarroki, Betty K. Hamilton, Sudipto Mukherjee, Matt Kalaycio, Ronald Sobecks, Anjali S. Advani, Mikkael A. Sekeres, Shashirekha Shetty...> ;Clinical Lymphoma, Myeloma & Leukemia. 2015 Aug 1
• 16 citations
  Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) c...
  Ali Tabarroki, Yogen Saunthararajah, Valeria Visconte, Tracy Cinalli, Kristin Colaluca, Heesun J. Rogers, Mikkael A. Sekeres, Hien K. Duong, Brady L. Stein, Ramon V. Tiu> ;Leukemia & Lymphoma. 2015 Feb 1
• 20 citations
  Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts
  Valeria Visconte, Ali Tabarroki, Li Zhang, Yvonne Parker, Edy Hasrouni, Reda Z. Mahfouz, Kyoichi Isono, Haruhiko Koseki, Mikkael A. Sekeres, Yogen Saunthararajah, John...> ;Journal of Hematology & Oncology. 2014 Dec 7
• 33 citations
  Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
  Paula de Melo Campos, João Agostinho Machado-Neto, Renata Scopim-Ribeiro, Valeria Visconte, Ali Tabarroki, Adriana S. S. Duarte, Flavia Fonseca de Carvalho Barra, José...> ;Leukemia Research. 2014 Oct 1
• 6 citations
  Molecular genetics of myelofibrosis and its associated disease phenotypes.
  Ali Tabarroki, Ramon V. Tiu> ;Translational Medicine @ Unisa. 2014 Feb 4
• 3 citations
  Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease
  Ali Tabarroki, Valeria Visconte, Heesun J. Rogers, Mikkael A. Sekeres, Christy J. Samaras, Alan E. Lichtin, Hien K. Duong, Ricki Englehaupt, Tracy Cinalli, Kristin Dod...> ;Leukemia & Lymphoma. 2014 Jan 1
• 4 citations
  A case of mistaken identity: When lupus masquerades as primary myelofibrosis
  Heesun J. Rogers, Ali Tabarroki, Valeria Visconte, Fabiola Traina, Manuel G. Afable, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Ramon V. Tiu, Edy Hasrouni> ;SAGE Open Medical Case Reports. 2013 Jan 1
• 11 citations
  Immunomodulatory agents in myelofibrosis.
  Ali Tabarroki, Ramon V. Tiu> ;Expert Opinion on Investigational Drugs. 2012 Jul 12
• Join now to see all